Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NABRIVA THERAPEUTICS PLC/ EFFECT

SEC Filing · EFFECT

NABRIVA THERAPEUTICS PLC

SEC Filing

Filed Oct 24, 2023Accepted Oct 24, 2023, 8:15 PM EDTCIK 1641640Accession 9999999995-23-003076
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
NBRVNASDAQ · EQUITY · Historical · closed Jul 31, 2023

Recent company filings

  1. 15-12G filingOct 25, 2023
  2. POS AM filingOct 20, 2023
  3. S-8 POS filingOct 20, 2023
  4. S-8 POS filingOct 20, 2023
  5. S-8 POS filingOct 20, 2023

As-filed source

Primary evidence
As filedOpen full document ↗